secwatch.observer — SEC 8-K summary
======================================

Issuer:     ASSEMBLY BIOSCIENCES, INC. (ASMB)
CIK:        0001426800
Form:       8-K
Filed at:   2026-05-26T20:10:16+00:00
Accession:  0001193125-26-239277
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Assembly Biosciences raises $115M gross in underwritten equity offering; underwriters exercise option in full
--------------------------------------------------------------------------------

- Closed offering of 3,924,624 common shares at $26.50 and pre-funded warrants for 415,000 shares at $26.499.
- Net proceeds of approximately $107.4M after underwriting discounts and estimated expenses.
- Investors include Gilead Sciences, Commodore Capital, Farallon Capital, and others.
- Proceeds to fund clinical development of pipeline candidates and for general corporate purposes.
- Underwriters' 30-day option for 566,040 additional shares exercised in full on May 22.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1426800/000119312526239277/0001193125-26-239277-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1426800/000119312526239277/asmb-20260521.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-239277

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer